8-K: Apyx Medical Appoints Shawn Roman as COO, Enters Employment Agreement

Apyx Medical Corporation has appointed Shawn Roman as Chief Operating Officer, effective January 28, 2025, and entered into an employment agreement outlining his compensation, benefits, and terms of employment.

Summary

• Apyx Medical Corporation has appointed Shawn Roman as its Chief Operating Officer (COO), effective January 28, 2025.
• The company and Mr. Roman have entered into an employment agreement that details the terms of his employment.
• Mr. Roman's initial annual base salary is set at $305,760.52.
• He is eligible for an annual bonus with a target of at least 50% of his base salary, contingent upon achieving bonus objectives.
• Mr. Roman can participate in the company's equity-based incentive plans.
• The agreement outlines terms for termination of employment, including conditions for severance payments and benefits, subject to a release and adherence to restrictive covenants.
• The employment agreement includes restrictive covenants such as non-competition, non-solicitation, and confidentiality clauses.

Sentiment

Score: 7

Explanation: The document is a standard employment agreement, indicating a neutral to slightly positive sentiment. The appointment of a COO is generally a positive step for a company, suggesting growth and operational focus.

Positives

• The appointment of a COO can strengthen the company's operational leadership.
• The employment agreement provides clarity and structure regarding compensation and responsibilities.
• The inclusion of equity-based incentives aligns the COO's interests with those of the shareholders.
• The agreement includes provisions for severance payments and benefits under certain termination scenarios, providing a level of security for the executive.
• Restrictive covenants protect the company's interests by preventing the executive from competing or soliciting employees/clients for a defined period after employment.

Negatives

• The agreement includes restrictive covenants that may limit the executive's future employment options.
• Termination for cause could result in the forfeiture of certain benefits.
• The bonus is subject to the achievement of objectives, which introduces uncertainty in compensation.

Risks

• The company's performance may be impacted if the COO does not effectively execute his responsibilities.
• The cost of severance payments could impact the company's financial performance in the event of termination without cause or for good reason.
• Legal disputes could arise if there are disagreements regarding the interpretation or enforcement of the employment agreement, particularly concerning the restrictive covenants or termination clauses.

Future Outlook

The company expects Shawn Roman to fulfill his duties as COO, contributing to the company's operational success. The employment agreement provides a framework for the relationship, including potential termination scenarios and associated compensation.

Management Comments

• The document does not contain direct quotes, but it implies that the company is confident in Shawn Roman's ability to perform his duties as COO.

Industry Context

Executive appointments and employment agreements are standard practice in publicly traded companies. The terms of the agreement, including compensation and restrictive covenants, are generally aligned with industry standards for similar positions.

Comparison to Industry Standards

• Base salary and bonus targets are generally in line with industry standards for COO positions at similar-sized medical device companies.
• Restrictive covenants, such as non-competition and non-solicitation clauses, are common in executive employment agreements to protect the company's interests.
• Severance provisions are also typical, with the specific terms varying based on the circumstances of termination.

Management Changes

Stakeholder Impact

• Shareholders may view the appointment of a COO as a positive step towards improving operational efficiency and driving growth.
• Employees may be impacted by changes in leadership and operational strategies implemented by the new COO.
• Customers and suppliers may experience changes in their interactions with the company as a result of the new COO's influence on operations.

Next Steps

• Shawn Roman will assume his responsibilities as COO, effective January 28, 2025.
• The Compensation Committee will determine and establish the annual bonus plan.
• The company will administer the employment agreement according to its terms.

Key Dates